OOIR: Observatory of International Research

Papers

(The median citation count of Endocrine Reviews is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Molecular Landscape and Therapeutic Strategies in Pediatric Differentiated Thyroid Carcinoma	418
Teprotumumab for the Treatment of Thyroid Eye Disease	294
Anti-obesity pharmacotherapy for patients with genetic obesity due to defects in the leptin-melanocortin pathway	252
Biological and Therapeutic Implications of the Tumor Microenvironment in Pituitary Adenomas	228
Preclinical Rodent Models for Human Bone Disease, Including a Focus on Cortical Bone	215
Historical aspects of testicular function: virility, androgen production and spermatogenesis	186
The Changing Face of Turner Syndrome	184
Papillary Craniopharyngioma: An Integrative and Comprehensive Review	160
How Protein Methylation Regulates Steroid Receptor Function	159
Erratum to: “The Relationship Between Bone and Reproductive Hormones Beyond Estrogens and Androgens”	156
New and Consolidated Therapeutic Options for Pubertal Induction in Hypogonadism: In-depth Review of the Literature	144
History of Adrenal Research: From Ancient Anatomy to Contemporary Molecular Biology	141
Phosphorylation-Dependent Regulation of Guanylyl Cyclase (GC)-A and Other Membrane GC Receptors	128
The Immune Landscape of Pheochromocytoma and Paraganglioma: Current Advances and Perspectives	108
Contemporary Biological Insights and Clinical Management of Craniopharyngioma	107
Epigenetic Dysregulation in Endometriosis: Implications for Pathophysiology and Therapeutics	103
Risks of Iodine Excess	84
Endocrine Manifestations and New Developments in Mitochondrial Disease	80
The Weight of Place: Built Environment Correlates of Obesity and Diabetes	75
Effects of Maternal Vitamin D Supplementation on Childhood Health	74
Personalized Management of Pheochromocytoma and Paraganglioma	71
The Congenital and Acquired Mechanisms Implicated in the Etiology of Central Precocious Puberty	70
The Role of Iodine for Thyroid Function in Lactating Women and Infants	68
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies	68
Time-restricted Eating for the Prevention and Management of Metabolic Diseases	68

Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia	67
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance	64
Correction to: “ER Stress in Cardiometabolic Diseases: From Molecular Mechanisms to Therapeutics”	62
Correction to: “Brown Adipose Tissue—A Translational Perspective”	60
New Insights into the Structure and Function of Class B1 GPCRs	58
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management	56
Coxsackievirus and Type 1 Diabetes: Diabetogenic Mechanisms and Implications for Prevention	55
Diabetes Mellitus, Energy Metabolism, and COVID-19	53
The Spectrum of the Prader–Willi-like Pheno- and Genotype: A Review of the Literature	51
Management of Growth Disorders in Puberty: GH, GnRHa, and Aromatase Inhibitors: A Clinical Review	51
Corrigendum to: Personalized Management of Pheochromocytoma and Paraganglioma	49
Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction	48
LGR4: A New Receptor Member in Endocrine and Metabolic Diseases	48
Insulin: A 100-Year-Old Discovery With a Fascinating History	46
Metformin, Cognitive Function, and Changes in the Gut Microbiome	45
Biomarkers to Guide Medical Therapy in Primary Aldosteronism	44
Mini-Puberty, Physiological and Disordered: Consequences, and Potential for Therapeutic Replacement	44
Fracture Healing in the Setting of Endocrine Diseases, Aging, and Cellular Senescence	42
The Metabolic Role and Therapeutic Potential of the Microbiome	39
Clinical, Pathophysiologic, Genetic, and Therapeutic Progress in Primary Bilateral Macronodular Adrenal Hyperplasia	37
Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs	37
Update on Adipose Tissue and Cancer	37
A State of Natriuretic Peptide Deficiency	37
A Century-long Journey From the Discovery of Insulin to the Implantation of Stem Cell–derived Islets	36
Molecular Mechanisms of PTH/PTHrP Class B GPCR Signaling and Pharmacological Implications	34
Subtyping of Primary Aldosteronism by Adrenal Venous Sampling	34
The Cortisol Awakening Response: Regulation and Functional Significance	33
Common and Uncommon Mouse Models of Growth Hormone Deficiency	32
Imaging of Pheochromocytomas and Paragangliomas	31
From Molecule to Behavior: Hypocretin/orexin Revisited From a Sex-dependent Perspective	28
Levothyroxine: Conventional and Novel Drug Delivery Formulations	28
The β Cell in Diabetes: Integrating Biomarkers With Functional Measures	28
Molecular Derangements and the Diagnosis of ACTH-Dependent Cushing’s Syndrome	28
Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns	27
Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement	27
Reevaluating the Role of Progesterone in Ovarian Cancer: Is Progesterone Always Protective?	27
The Molecular Biology of Midgut Neuroendocrine Neoplasms	26
Current and Future Advances in Surgical Therapy for Pituitary Adenoma	25
The Search for the Causes of Common Hyperandrogenism, 1965 to Circa 2015	25
The Hypothalamus-pituitary-adrenocortical Response to Critical Illness: A Concept in Need of Revision	25
Crosstalk Between the Neuroendocrine System and Bone Homeostasis	25
Membrane-Initiated Estrogen, Androgen, and Progesterone Receptor Signaling in Health and Disease	24
Advances in Type 1 Diabetes Prediction Using Islet Autoantibodies: Beyond a Simple Count	23
The Glucocorticoid Receptor: Isoforms, Functions, and Contribution to Glucocorticoid Sensitivity	22
New Horizons in Klinefelter Syndrome: Current Evidence, Gaps, and Research Priorities	22
Arcuate Nucleus-Dependent Regulation of Metabolism—Pathways to Obesity and Diabetes Mellitus	22
International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood	22
Endotrophin, a Key Marker and Driver for Fibroinflammatory Disease	22
Secondary Osteoporosis	20
Biochemical Assessment of Pheochromocytoma and Paraganglioma	20

Fat Cell Size: Measurement Methods, Pathophysiological Origins, and Relationships With Metabolic Dysregulations	19
Adiponectin and Adiponectin Receptors in Atherosclerosis	19